SHEN Kun-wei, LIAO Ning. Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel,and Epirubicin Chemotherapy[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
|
Citation:
|
SHEN Kun-wei, LIAO Ning. Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel,and Epirubicin Chemotherapy[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
|
SHEN Kun-wei, LIAO Ning. Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel,and Epirubicin Chemotherapy[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
|
Citation:
|
SHEN Kun-wei, LIAO Ning. Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel,and Epirubicin Chemotherapy[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
|
DownLoad: